Ginkgo Bioworks Holdings, Inc. (DNA)

CIK 1830214 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ginkgo Bioworks Holdings, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 20268-K0001628280-26-071022
Oct 29, 20268-K0001628280-26-068220
Oct 21, 202640001628280-26-066704
Oct 21, 202640001628280-26-066706
Oct 21, 202640001628280-26-066705
Oct 21, 202640001628280-26-066703
Oct 19, 20261440001959173-26-007419
Oct 19, 20261440001959173-26-007421
Oct 19, 20261440001959173-26-007420
Oct 19, 20261440001959173-26-007422
Oct 19, 20261440001959173-26-007418
Oct 19, 20261440001959173-26-007415
Oct 7, 202640001628280-26-065349
Oct 5, 20261440001959173-26-007259
Sep 17, 20261440001959173-26-007017
Sep 16, 202640001628280-26-062239
Sep 15, 20261440001959173-26-006973
Aug 25, 202640001628280-26-058939
Aug 24, 20261440001959173-26-006388
Aug 17, 20261440001959173-26-006078
Aug 6, 202610-Q0001628280-26-054298
Aug 5, 20268-K0001628280-26-053319
Jul 30, 202640001628280-26-051089
Jul 30, 2026SCHEDULE 13G/A0002012383-26-003187
Jul 30, 20268-K0001628280-26-051041